Context Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	10.09	14.45	35.5	49.69	0.34	0.23
Cash & Cash Equivalents	10.09	14.45	35.5	49.69	0.34	0.23
Cash Growth	-66.11%	-59.29%	-28.56%	14468.97%	50.50%	-
Other Current Assets	0.95	1.6	2.36	1.57	-0.04	0.01
Total Current Assets	11.04	16.05	37.85	51.26	0.3	0.24
Property, Plant & Equipment	0.01	0.02	0.08	0	0	0
Other Long-Term Assets	0	0	0.03	0.05	0.17	0.03
Total Long-Term Assets	0.01	0.02	0.11	0.05	0.17	0.03
Total Assets	11.05	16.06	37.97	51.31	0.47	0.27
Accounts Payable	2.05	2.38	0.94	1.83	2.71	2.07
Current Debt	0	0	0.06	0	5.88	21.84
Other Current Liabilities	0.56	1.81	2.22	1.21	0.96	0.2
Total Current Liabilities	2.61	4.19	3.21	3.03	9.55	24.11
Long-Term Debt	0	0	0	0	0.07	0
Total Long-Term Liabilities	0	0	0	0	0.07	0
Total Liabilities	2.61	4.19	3.21	3.03	9.62	24.11
Total Debt	0	0	0.06	0	5.95	21.84
Debt Growth	-	-	-	-	-72.74%	-
Retained Earnings	-71.72	-68.05	-44.09	-29.25	-18.8	-25.44
Shareholders' Equity	8.44	11.87	34.76	48.27	-16.92	-23.96
Net Cash / Debt	10.09	14.45	35.44	49.69	-5.61	-21.62
Net Cash / Debt Growth	-66.07%	-59.23%	-28.67%	-	-	-
Net Cash Per Share	0.63	0.91	2.22	17.53	-2.73	-
Working Capital	8.43	11.86	34.65	48.22	-9.25	-23.87
Book Value Per Share	0.53	0.74	2.18	17.04	-48.57	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).